Back
37
Also listed as
TCYMF
OTC
Day Range
$32.63
$33.85
52-Week Range
$26.20
$37.30
Volume
452
50D / 200D Avg
$32.34
/
$30.11
Prev Close
$32.64
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 2.2 | 10.5 |
| P/B | 0.6 | 1.2 |
| ROE % | 30.0 | 12.3 |
| Net Margin % | 5.7 | 5.3 |
| Rev Growth 5Y % | 0.9 | 5.5 |
| D/E | 1.0 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.00
$0.00 – $0.00
|
590 B | 0 |
| FY2026 |
$0.00
$0.00 – $0.00
|
570 B | 0 |
Key Takeaways
Revenue grew 0.94% annually over 5 years — modest growth
Earnings grew 17.24% over the past year
ROE of 29.97% indicates high profitability
Generating 4.66B in free cash flow
P/E of 2.17 — trading at a low valuation
PEG of 0.76 suggests growth is underpriced
Growth
Revenue Growth (5Y)
0.94%
Revenue (1Y)-4.63%
Earnings (1Y)17.24%
FCF Growth (3Y)94.05%
Quality
Return on Equity
29.97%
ROIC15.47%
Net Margin5.69%
Op. Margin8.11%
Safety
Debt / Equity
1.02
Current Ratio0.72
Interest Coverage19.98
Valuation
P/E Ratio
2.17
P/B Ratio0.63
EV/EBITDA2.24
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4.63% | Revenue Growth (3Y) | -2.20% |
| Earnings Growth (1Y) | 17.24% | Earnings Growth (3Y) | 18.51% |
| Revenue Growth (5Y) | 0.94% | Earnings Growth (5Y) | 3.59% |
| Profitability | |||
| Revenue (TTM) | 76.91B | Net Income (TTM) | 4.38B |
| ROE | 29.97% | ROA | 7.96% |
| Gross Margin | 34.82% | Operating Margin | 8.11% |
| Net Margin | 5.69% | Free Cash Flow (TTM) | 4.66B |
| ROIC | 15.47% | FCF Growth (3Y) | 94.05% |
| Safety | |||
| Debt / Equity | 1.02 | Current Ratio | 0.72 |
| Interest Coverage | 19.98 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | 2.17 | P/B Ratio | 0.63 |
| P/S Ratio | 0.12 | PEG Ratio | 0.76 |
| EV/EBITDA | 2.24 | Dividend Yield | 0.06% |
| Market Cap | 9.52B | Enterprise Value | 13.94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 76.91B | 80.65B | 80.42B | 78.72B | 74.08B |
| Net Income | 4.38B | 3.73B | 3.12B | 2.63B | 3.80B |
| EPS (Diluted) | 15.60 | 13.20 | 11.00 | 9.40 | 13.60 |
| Gross Profit | 26.78B | 26.70B | 24.47B | 22.90B | 22.51B |
| Operating Income | 6.24B | 5.88B | 3.91B | 3.33B | 4.33B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 54.97B | 53.15B | 53.15B | 58.45B | 60.31B |
| Total Liabilities | 36.46B | 35.53B | 35.93B | 41.63B | 37.90B |
| Shareholders' Equity | 14.99B | 14.23B | 13.89B | 13.37B | 18.66B |
| Total Debt | 15.24B | 13.52B | 14.06B | 17.92B | 14.02B |
| Cash & Equivalents | 10.82B | 7.52B | 6.75B | 12.32B | 15.84B |
| Current Assets | 21.26B | 17.99B | 20.47B | 24.03B | 25.67B |
| Current Liabilities | 29.38B | 32.42B | 29.19B | 31.70B | 29.83B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#262 of 670
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026